Drug Type Synthetic peptide |
Synonyms Taspoglutide (USAN/INN), BIM 51077, BIM-51077 + [10] |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC152H232N40O45 |
InChIKeyWRGVLTAWMNZWGT-VQSPYGJZSA-N |
CAS Registry275371-94-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09723 | Taspoglutide | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Phase 3 | US | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | AU | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | BR | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | BG | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | CA | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | CZ | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | DK | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | EE | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | DE | 01 Jan 2010 | |
Cardiovascular Diseases | Phase 3 | HU | 01 Jan 2010 |
Phase 3 | 1,189 | eudxkplznd(pcnxkaffgk) = geodsnpgbp zwkvuumivb (dnadssinbt ) View more | - | 01 Mar 2013 | |||
eudxkplznd(pcnxkaffgk) = jpyttxkorg zwkvuumivb (dnadssinbt ) View more | |||||||
Phase 2 | 306 | gsuqldkylp(yhsclajxks) = xsukygsukh znndqgehol (tvmxicorhl ) View more | Positive | 01 Jul 2009 | |||
gsuqldkylp(yhsclajxks) = cfciuxgeyj znndqgehol (tvmxicorhl ) View more |